Nothing Special   »   [go: up one dir, main page]

Alvarez et al., 2022 - Google Patents

Modeling Alzheimer's disease in caenorhabditis elegans

Alvarez et al., 2022

View HTML
Document ID
14370953884990729669
Author
Alvarez J
Alvarez-Illera P
Santo-Domingo J
Fonteriz R
Montero M
Publication year
Publication venue
Biomedicines

External Links

Snippet

Alzheimer's disease (AD) is the most frequent cause of dementia. After decades of research, we know the importance of the accumulation of protein aggregates such as β-amyloid peptide and phosphorylated tau. We also know that mutations in certain proteins generate …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Similar Documents

Publication Publication Date Title
Alvarez et al. Modeling Alzheimer’s disease in caenorhabditis elegans
Aikawa et al. ABCA7 and pathogenic pathways of Alzheimer’s disease
Wang et al. Zebrafish and medaka: important animal models for human neurodegenerative diseases
Chami et al. Alterations of the endoplasmic reticulum (ER) calcium signaling molecular components in Alzheimer’s disease
Medina et al. New features about tau function and dysfunction
Hasegawa Molecular mechanisms in the pathogenesis of Alzheimer’s disease and tauopathies-prion-like seeded aggregation and phosphorylation
Alvarez et al. The role of Ca2+ signaling in aging and neurodegeneration: insights from Caenorhabditis elegans models
Schulz-Schaeffer Is cell death primary or secondary in the pathophysiology of idiopathic Parkinson’s disease?
Shirafuji et al. Homocysteine increases tau phosphorylation, truncation and oligomerization
Jeon et al. Genetic dissection of Alzheimer’s disease using Drosophila models
Patro et al. ATP synthase and mitochondrial bioenergetics dysfunction in Alzheimer’s disease
Barczuk et al. Targeting NLRP3-mediated neuroinflammation in Alzheimer’s disease treatment
Toni et al. Fish synucleins: an update
Kim et al. Autophagy and human neurodegenerative diseases—a fly’s perspective
Vacchi et al. Tau and alpha synuclein synergistic effect in neurodegenerative diseases: When the periphery is the core
Brunetti et al. Role of PITRM1 in mitochondrial dysfunction and neurodegeneration
Angel et al. Caspase-6 knockout in the 5xFAD model of Alzheimer’s disease reveals favorable outcome on memory and neurological hallmarks
Carroll et al. Tau post-translational modifications: potentiators of selective vulnerability in sporadic Alzheimer’s disease
Sarasija et al. Role of presenilin in mitochondrial oxidative stress and neurodegeneration in Caenorhabditis elegans
Giong et al. Non-rodent genetic animal models for studying tauopathy: review of Drosophila, zebrafish, and C. elegans models
Penke et al. New pathways identify novel drug targets for the prevention and treatment of Alzheimer’s disease
Olesnicky et al. Drosophila as a model for assessing the function of RNA-binding proteins during neurogenesis and neurological disease
Kristofova et al. Multifaceted microcephaly-related gene MCPH1
Wasilewska et al. stim2b knockout induces hyperactivity and susceptibility to seizures in zebrafish larvae
Alyenbaawi et al. Prion-like propagation mechanisms in tauopathies and traumatic brain injury: Challenges and prospects